[Current medical treatment of Parkinsonian syndromes].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000601:surgery; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*
D000978:Antiparkinson Agents; D004338:Drug Combinations; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D000547:Amantadine
Thérapie médicale actuelle des syndromes parkinsoniens.